title: Switching to amisulpride due to hepatic complications.
authors.affiliation: University Hospital Eppendorf, Clinic for Psychiatry and Psychotherapy, Martinistr. 52, 20246, Hamburg, Germany. yagdiran@uke.uni-hamburg.de
authors.forename: Oktay
authors.initials: O
authors.lastname: Yagdiran
authors.forename: Christian
authors.initials: C
authors.lastname: Haasen
authors.forename: Evangelia
authors.initials: E
authors.lastname: Nika
authors.forename: Michael
authors.initials: M
authors.lastname: Krausz
authors.forename: Dieter
authors.initials: D
authors.lastname: Naber
mesh_terms: D000328:Adult; D000077582:Amisulpride; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D056486:Chemical and Drug Induced Liver Injury; D005475:Flupenthixol / Q000009:adverse effects*; D006220:Haloperidol / Q000009:adverse effects* / Q000031:analogs & derivatives*; D006801:Humans; D008297:Male; D010464:Perazine / Q000009:adverse effects*; D012559:Schizophrenia / Q000188:drug therapy*; D013469:Sulpiride / Q000031:analogs & derivatives* / Q000627:therapeutic use*
chemical_list: D014150:Antipsychotic Agents; D013469:Sulpiride; D000077582:Amisulpride; D010464:Perazine; D005475:Flupenthixol; D006220:Haloperidol; C006820:bromperidol